Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Nepal G, Kharel S, Coghlan MA, Rayamajhi P, et al. Safety and efficacy of rituximab for relapse prevention in myelin oligodendrocyte glycoprotein immunoglobulin G (MOG-IgG)-associated disorders (MOGAD): A systematic review and meta-analysis. J Neuroimmunol 2022;364:577812.
PMID: 35063726


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016